LongALKSJun 2026
Alkermes
Baird initiated a position in Alkermes as part of its increased exposure to commercial-stage therapeutics. The company is one of only a few businesses with a leading product in…
ALKS
2 published ideas on Alkermes across 2 funds — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Alkermes: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Baird initiated a position in Alkermes as part of its increased exposure to commercial-stage therapeutics. The company is one of only a few businesses with a leading product in…
Baird added Alkermes as part of its increased exposure to commercial-stage therapeutics. The fund highlights Alkermes as one of a small number of companies with a leading product…